Acorda Therapeutics Inc (ACORQ)
0.605
+0.10
(+18.63%)
USD |
OTCM |
May 17, 16:00
Acorda Therapeutics Cash from Operations (Quarterly): -20.18M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -20.18M |
| December 31, 2023 | -3.018M |
| September 30, 2023 | 7.608M |
| June 30, 2023 | -11.56M |
| March 31, 2023 | -7.018M |
| December 31, 2022 | 9.066M |
| September 30, 2022 | -1.839M |
| June 30, 2022 | -14.51M |
| March 31, 2022 | -13.64M |
| December 31, 2021 | 3.24M |
| September 30, 2021 | -9.012M |
| June 30, 2021 | -8.688M |
| March 31, 2021 | -26.89M |
| December 31, 2020 | 1.448M |
| September 30, 2020 | -2.905M |
| June 30, 2020 | -20.77M |
| March 31, 2020 | -38.78M |
| December 31, 2019 | -11.43M |
| September 30, 2019 | -24.35M |
| June 30, 2019 | -14.89M |
| March 31, 2019 | -77.50M |
| December 31, 2018 | -12.34M |
| September 30, 2018 | 78.17M |
| June 30, 2018 | 56.26M |
| March 31, 2018 | 28.70M |
| Date | Value |
|---|---|
| December 31, 2017 | 60.53M |
| September 30, 2017 | 51.76M |
| June 30, 2017 | 10.26M |
| March 31, 2017 | -25.42M |
| December 31, 2016 | 26.78M |
| September 30, 2016 | 5.725M |
| June 30, 2016 | -9.55M |
| March 31, 2016 | 6.697M |
| December 31, 2015 | 22.32M |
| September 30, 2015 | 22.16M |
| June 30, 2015 | 3.25M |
| March 31, 2015 | -9.25M |
| December 31, 2014 | 13.22M |
| September 30, 2014 | 38.42M |
| June 30, 2014 | 18.71M |
| March 31, 2014 | 4.305M |
| December 31, 2013 | 19.19M |
| September 30, 2013 | 19.44M |
| June 30, 2013 | 8.308M |
| March 31, 2013 | -7.655M |
| December 31, 2012 | 16.74M |
| September 30, 2012 | 20.02M |
| June 30, 2012 | 12.35M |
| March 31, 2012 | 3.012M |
| December 31, 2011 | 32.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-38.78M
Minimum
Mar 2020
9.066M
Maximum
Dec 2022
-10.41M
Average
-10.22M
Median
Cash from Operations (Quarterly) Benchmarks
| BioSig Technologies Inc | -2.942M |
| Verve Therapeutics Inc | -43.08M |
| Spectral AI Inc | -5.338M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 4.188M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -27.15M |
| Free Cash Flow Per Share (Quarterly) | -16.25 |
| Free Cash Flow to Equity (Quarterly) | -25.52M |
| Free Cash Flow to Firm (Quarterly) | -11.92M |
| Free Cash Flow Yield | -3.61K% |